Showing results (171-180 of 426) with videos related to

Sort By:
Pageof 43
Circulation|June 25, 2003
Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacksAndrea M Russo, Gail E Hafley, Kerry L Lee, et al.
Ugeskrift for Laeger|April 29, 2022
[Transanal endoscopic microsurgery for excision of a symptomatic tailgut cyst]Daniel Mark Skovgaards, Nis Hallundbæk Schlesinger, Andreas Nordholm-Carstensen
The Journal of Emergency Medicine|August 6, 2013
Stress cardiomyopathy: case series and the review of literatureVinoda Sharma, Manivannan Srinivasan, Daniel Mark Sheehan, et al.
Biophysical Journal|April 15, 2026
TopClust: Topological-based analysis of scRNA-seq data for data-driven identification of clusters and core cluster cellsChuansheng Hu, Daniel Mark Czajkowsky, Jie Liang, et al.
Journal of Cardiovascular Computed Tomography|April 8, 2019
Effects of obesity on noninvasive test results in patients with suspected cardiac ischemia: Insights from the PROMISE trialSheldon E Litwin, Adrian Coles, Neha Pagidipati, et al.
Circulation|May 9, 2007
Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Ronald S Freudenberger, Anne S Hellkamp, Jonathan L Halperin, et al.
American Heart Journal|March 12, 2011
The Occluded Artery Trial (OAT) Viability Ancillary Study (OAT-NUC): influence of infarct zone viability on left ventricular remodeling after percutaneous coronary intervention versus optimal medical therapy aloneJames E Udelson, Camille A Pearte, Carey D Kimmelstiel, et al.
Heart Rhythm|November 27, 2010
Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Jonathan P Piccini, Sana M Al-Khatib, Anne S Hellkamp, et al.
The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.
Journal of the American College of Cardiology|April 15, 2014
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial)Daniel P Fishbein, Anne S Hellkamp, Daniel B Mark, et al.
Pageof 43